171 related articles for article (PubMed ID: 25653146)
1. BAD-mediated apoptotic pathway is associated with human cancer development.
Stickles XB; Marchion DC; Bicaku E; Al Sawah E; Abbasi F; Xiong Y; Bou Zgheib N; Boac BM; Orr BC; Judson PL; Berry A; Hakam A; Wenham RM; Apte SM; Berglund AE; Lancaster JM
Int J Mol Med; 2015 Apr; 35(4):1081-7. PubMed ID: 25653146
[TBL] [Abstract][Full Text] [Related]
2. Bad expression predicts outcome in patients treated with tamoxifen.
Cannings E; Kirkegaard T; Tovey SM; Dunne B; Cooke TG; Bartlett JM
Breast Cancer Res Treat; 2007 Apr; 102(2):173-9. PubMed ID: 17004114
[TBL] [Abstract][Full Text] [Related]
3. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
Jian J; Hu ZF; Huang Y
Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
[TBL] [Abstract][Full Text] [Related]
4. The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Chon HS; Marchion DC; Xiong Y; Chen N; Bicaku E; Stickles XB; Bou Zgheib N; Judson PL; Hakam A; Gonzalez-Bosquet J; Wenham RM; Apte SM; Lancaster JM
Gynecol Oncol; 2012 Jan; 124(1):119-24. PubMed ID: 22032837
[TBL] [Abstract][Full Text] [Related]
5. BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival.
Marchion DC; Cottrill HM; Xiong Y; Chen N; Bicaku E; Fulp WJ; Bansal N; Chon HS; Stickles XB; Kamath SG; Hakam A; Li L; Su D; Moreno C; Judson PL; Berchuck A; Wenham RM; Apte SM; Gonzalez-Bosquet J; Bloom GC; Eschrich SA; Sebti S; Chen DT; Lancaster JM
Clin Cancer Res; 2011 Oct; 17(19):6356-66. PubMed ID: 21849418
[TBL] [Abstract][Full Text] [Related]
6. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase type 2C dephosphorylates BAD.
Klumpp S; Selke D; Krieglstein J
Neurochem Int; 2003 Jun; 42(7):555-60. PubMed ID: 12590938
[TBL] [Abstract][Full Text] [Related]
8. Bad phosphorylation as a target of inhibition in oncology.
Bui NL; Pandey V; Zhu T; Ma L; Basappa ; Lobie PE
Cancer Lett; 2018 Feb; 415():177-186. PubMed ID: 29175460
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression.
Zhou B; Yang J; Shu B; Liu K; Xue L; Su N; Liu J; Xi T
Mol Med Rep; 2015 Apr; 11(4):2981-90. PubMed ID: 25483832
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222
[TBL] [Abstract][Full Text] [Related]
11. PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.
Desai S; Pillai P; Win-Piazza H; Acevedo-Duncan M
Biochim Biophys Acta; 2011 Jun; 1813(6):1190-7. PubMed ID: 21419810
[TBL] [Abstract][Full Text] [Related]
12. Pisiferdiol and pisiferic acid isolated from Chamaecyparis pisifera activate protein phosphatase 2C in vitro and induce caspase-3/7-dependent apoptosis via dephosphorylation of Bad in HL60 cells.
Aburai N; Yoshida M; Ohnishi M; Kimura K
Phytomedicine; 2010 Aug; 17(10):782-8. PubMed ID: 20153620
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
14. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
16. Role of Increased n-acetylaspartate Levels in Cancer.
Zand B; Previs RA; Zacharias NM; Rupaimoole R; Mitamura T; Nagaraja AS; Guindani M; Dalton HJ; Yang L; Baddour J; Achreja A; Hu W; Pecot CV; Ivan C; Wu SY; McCullough CR; Gharpure KM; Shoshan E; Pradeep S; Mangala LS; Rodriguez-Aguayo C; Wang Y; Nick AM; Davies MA; Armaiz-Pena G; Liu J; Lutgendorf SK; Baggerly KA; Eli MB; Lopez-Berestein G; Nagrath D; Bhattacharya PK; Sood AK
J Natl Cancer Inst; 2016 Jan; 108(6):djv426. PubMed ID: 26819345
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
18. Α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling.
Zhuo RJ; Wang F; Zhang XH; Zhang JJ; Xu J; Dong W; Zou ZQ
Mol Med Rep; 2014 Mar; 9(3):993-8. PubMed ID: 24425042
[TBL] [Abstract][Full Text] [Related]
19. Phosphatases and regulation of cell death.
Chiang CW; Yan L; Yang E
Methods Enzymol; 2008; 446():237-57. PubMed ID: 18603126
[TBL] [Abstract][Full Text] [Related]
20. p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
Lu P; Redd Bowman KE; Brown SM; Joklik-Mcleod M; Vander Mause ER; Nguyen HTN; Lim CS
Mol Pharm; 2019 Aug; 16(8):3386-3398. PubMed ID: 31241338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
